Artiva Biotherapeutics, Inc. ARTV Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s other accrued liabilities?
- Artiva Biotherapeutics, Inc. (ARTV) reported other accrued liabilities of $1.13M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s other accrued liabilities changed year-over-year?
- Artiva Biotherapeutics, Inc.'s other accrued liabilities increased by 35.1% year-over-year, from $835K to $1.13M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s other accrued liabilities?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s other accrued liabilities has grown at a -3.9% compound annual growth rate (CAGR), from $1.11M to $1.02M.